Now I have enough data to calibrate. Let me analyze the anchors and finalize my review.

**Calibration Analysis:**

The anchors show a clear pattern:
- **Rejected (2.5–4.5):** Mamba-HMIL (3.25, similar MIL-for-WSI topic but poor writing and unmotivated components), MILCA (3.50, MIL method with fundamental issues), SMIL (4.50, decent but limited novelty)
- **Borderline accepted (5.5–6.0):** MFC (6.00, novel causal framework for MIL/WSI with high reviewer variance 3-8), set-level labels (5.67, novel pretraining with theoretical backing), VLSA (5.67, novel VL approach with marginal improvements)
- **Strong accepted (8.0):** Different topic areas (time series MIL, diffusion, CLIP interpretation)

**Where HOMIL sits:** HOMIL is clearly better than the rejected papers (cleaner motivation, cleaner ablation, massive efficiency gains, better writing). It's comparable to the borderline-accepted papers: it has a clear conceptual contribution (second-order moments), a clean ablation, and strong efficiency gains, but the accuracy improvements over the best baselines are small and untested for significance. Like VLSA (5.67) and the set-level labels paper (5.67), it has a solid idea with modest empirical margins. The efficiency gains (6–23× faster) are a genuine differentiator. I bracket this at **5.0–6.0**.

Given the efficiency story is stronger than most anchors, the ablation is clean, but the overclaimed "significant" improvements and method inconsistencies hold it back, I settle on **5.5**.

---

## Summary
This paper proposes HOMIL, a multi-instance learning framework for whole-slide image (WSI) classification that augments standard attention-weighted mean aggregation with a second-order covariance matrix computed over DBSCAN cluster representations. The method is evaluated on CAMELYON16 and TCGA-NSCLC, claiming state-of-the-art accuracy with 6–23× computational efficiency gains over recent baselines.

## Strengths
- **Clear statistical reinterpretation of ABMIL as first-order moment estimation**: Section 3.1 (lines 59–63) formulates ABMIL's aggregation as μ = E_{a_i}[h_i], providing principled motivation for adding second-order statistics rather than an ad hoc architectural extension. This framing connects the method to classical statistics and makes the contribution interpretable.
- **Clean ablation study validating each component's contribution**: Table 3 on CAMELYON16 isolates CM and SOM contributions. Removing CM drops ACC by 1.26% and increases runtime by 71%; removing SOM drops ACC by 1.0% and F1 by 1.6%; removing both recovers the ABMIL baseline (94.72%). This demonstrates complementary contributions.
- **Substantial computational efficiency gains**: HOMIL achieves 310s total 5-fold runtime on CAMELYON16 vs. 7200s for MambaMIL and 10800s for HMIL (Table 1). On TCGA-NSCLC, 3685s vs. 48710s for TransMIL (Table 2). Notably, these times include clustering overhead for HOMIL (line 240), making this a conservative comparison that understates HOMIL's efficiency advantage.
- **Unified experimental comparison**: All nine baselines are implemented in a single codebase with identical 5-fold patient-level cross-validation splits (lines 200–204), eliminating implementation confounds.
- **Consistent improvements over ABMIL across tasks**: HOMIL improves over ABMIL by +2.26% ACC on CAMELYON16 and +2.19% on TCGA-NSCLC, validating the core claim that second-order moments provide value over first-order-only aggregation.

## Weaknesses

### Fatal
None

### Major
- **No statistical significance tests despite small margins over the best baselines**: The improvements over the best-performing baselines are modest (e.g., 0.50% ACC over MambaMIL on CAMELYON16 with SE 1.37%; 0.35% ACC over HMIL on TCGA-NSCLC with SE 1.45%). The paper repeatedly uses "significantly improves" (Abstract, line 9) and "outperforming all baselines" (Section 5.3) without any paired statistical tests. While the improvements over ABMIL are larger and more convincing, the headline claim of SOTA performance requires significance testing. This is the primary weakness: the paper's strongest empirical claim is not statistically established.
- **Mismatch between patch-level motivation and cluster-level implementation**: Section 3.2 motivates the covariance Σ = Σ(h_i − μ)(h_i − μ)^T over patch features {h_i} (lines 71–73), but the actual computation in Section 4.3.3 uses cluster features {g_k} which are mean-pooled aggregations (line 103). This averages away inter-patch variability before computing second-order statistics. The paper transparently states this (line 25) but does not analyze how this affects the statistical properties of the resulting matrix or whether it still captures the intended inter-patch variability.
- **The "attention-weighted covariance matrix" label is misleading**: Lines 108 and 147 describe "an attention-weighted covariance matrix," but Eq. C = Σ g̃_k g̃_k^T (line 152) applies equal weight to all clusters in the summation. Only the centering uses the attention-weighted mean v^(1). This is inconsistent with the first-order computation where clusters are weighted by attention a_k (line 141), and the paper does not discuss or justify this asymmetry.

### Minor
- **Covariance compression scheme is unmotivated**: The 512×512 covariance matrix is compressed to 512 dimensions via row-wise 1D convolution (4 kernels of dim 64) + two-stage max-pooling (Eqs. 4–5, lines 160–168). This is extremely lossy (262,144 → 512 elements), and no alternative compression schemes are compared. Since the entire contribution rests on extracting useful second-order signal, understanding what information survives this compression would significantly strengthen the paper.
- **DBSCAN's density-adaptive property is assumed but not validated**: The paper claims DBSCAN "naturally forms small clusters for rare pathological regions and large clusters for abundant normal tissues" (lines 116–117), but provides no spatial visualization or cluster-level label analysis to confirm clusters correspond to diagnostically meaningful regions. The only evidence is aggregate compression ratios (0.18, 0.16 in Section 5.3).
- **Limited evaluation scope**: Only two datasets, both binary classification (metastasis detection, LUAD vs. LUSC subtyping). A third dataset or more challenging task (e.g., multi-class grading, survival prediction) would strengthen generalizability claims.
- **"ABML" typo on line 107** where "ABMIL" is intended.

### Trivial
None

## Nice-to-Haves
- Visualize DBSCAN clusters overlaid on WSIs to validate the density-adaptive claim
- Compare 1D-conv compression to simpler alternatives (eigenvalue decomposition, learned linear projection on flattened upper triangle)
- Report Wilcoxon signed-rank or permutation tests on fold-level paired results
- Analyze what the covariance representation encodes that the first-order does not

## Removed Points
These points are flagged to be removed, treat them with caution:
- **Time comparison asymmetry**: The harsh critic flagged that HOMIL includes clustering time while baselines include only training+inference. However, this asymmetry FAVORS the baselines — HOMIL's runtime is overstated relative to comparison methods, making its efficiency gains MORE impressive. This is conservative reporting, not a weakness.
- **Missing graph-based MIL in related work**: Cannot verify existence or relevance without external sources.
- **ABMIL special case claim needs formal proof**: Minor theoretical point that doesn't affect the empirical contribution.

## Novel Insights
The paper's most novel contribution is the statistical reinterpretation of ABMIL as first-order moment estimation (Section 3.1), which provides a principled and generalizable framework for motivating higher-order statistics in MIL. Combined with DBSCAN-based adaptive clustering that exploits the natural structure of histopathological images, this yields a conceptually clean and computationally efficient extension. The efficiency gains (6–23× faster) combined with the clean ablation validating complementary CM and SOM contributions make this more than incremental, though the accuracy margins over the best non-ABMIL baselines remain modest.

## Suggestions
1. Add paired statistical significance tests (Wilcoxon signed-rank on 5-fold results) for all pairwise comparisons with best baselines. If significance cannot be established, honestly frame improvements as modest and emphasize efficiency.
2. Correct the "attention-weighted" label — either add attention weights to the covariance summation to match the label, or relabel it as "centered around attention-weighted mean."
3. Acknowledge and discuss the gap between patch-level motivation and cluster-level implementation.
4. Add an ablation comparing the 1D-conv compression to at least one simpler alternative.

## Calibration Anchors
| Anchor | Score | Round | Comparison |
|--------|-------|-------|------------|
| Mamba-HMIL | 3.25 | R1 | Similar topic (MIL for WSI), rejected for poor writing and unmotivated components. HOMIL is clearly stronger. |
| SHAP-CAT | 3.40 | R1 | WSI framework, rejected for novelty concerns. HOMIL has cleaner motivation. |
| MILCA | 3.50 | R1 | MIL method, rejected for fundamental issues. HOMIL is clearly better. |
| SMIL | 4.50 | R1 | Sequential MIL, rejected despite decent methodology. HOMIL has stronger ablation and efficiency. |
| MFC | 6.00 | R1 | Similar domain (MIL for WSI), accepted with high variance (3,8,3,8). More ambitious but weaker execution. |
| Set-level labels | 5.67 | R1 | Novel pretraining for MIL, accepted with marginal improvements. Comparable contribution level. |
| VLSA | 5.67 | R1 | Novel VL approach for WSI survival, accepted with marginal improvements. HOMIL has stronger efficiency story. |
| MIL for TSC | 8.00 | R1 | Different domain (time series). Much stronger novelty/interpretability. Not comparable. |

**Round-1 bracket: 5.0–6.0.** HOMIL is clearly above the rejected papers (2.5–4.5) and comparable to the borderline-accepted papers (5.5–6.0), with stronger efficiency gains but weaker significance for accuracy claims. Final score 5.5, reflecting a solid contribution with a clean ablation and genuine efficiency advantages, held back by overclaimed accuracy improvements and method inconsistencies.

MY FINAL SCORE: <score>5.5</score>
MY FINAL DECISION: <decision>Reject</decision>